NO166865C - Analogifremgangsmaate til fremstilling av terapeutisk aktive o-glykosidforbindelser. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive o-glykosidforbindelser.

Info

Publication number: NO166865C
Authority: NO; Norway
Prior art keywords: preparation; therapeutically active; glycoside compounds; analogue procedure; analogue
Prior art date: 1985-01-14

Application number

NO863645A

Other languages

English (en)

Other versions

NO863645D0 (no

NO166865B (no

NO863645L (no

Inventor

Hans Goeran Magnusson

Torbjoern Frejd

Original Assignee

Symbicom Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-01-14

Filing date

1986-09-12

Publication date

1991-09-11

1986-09-12 Application filed by Symbicom Ab filed Critical Symbicom Ab

1986-09-12 Publication of NO863645D0 publication Critical patent/NO863645D0/no

1986-11-13 Publication of NO863645L publication Critical patent/NO863645L/no

1991-06-03 Publication of NO166865B publication Critical patent/NO166865B/no

1991-09-11 Publication of NO166865C publication Critical patent/NO166865C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
Cell Biology (AREA)
Crystallography & Structural Chemistry (AREA)
Pathology (AREA)
General Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Communicable Diseases (AREA)
Polymers & Plastics (AREA)
Materials Engineering (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Tropical Medicine & Parasitology (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Detergent Compositions (AREA)

NO863645A 1985-01-14 1986-09-12 Analogifremgangsmaate til fremstilling av terapeutisk aktive o-glykosidforbindelser. NO166865C (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK17685A DK17685D0 (da)	1985-01-14	1985-01-14	Glycosidderivater
PCT/DK1986/000006 WO1986004065A1 (en)	1985-01-14	1986-01-13	Glycosidic derivatives

Publications (4)

Publication Number	Publication Date
NO863645D0 NO863645D0 (no)	1986-09-12
NO863645L NO863645L (no)	1986-11-13
NO166865B NO166865B (no)	1991-06-03
NO166865C true NO166865C (no)	1991-09-11

Family

ID=8090628

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO863645A NO166865C (no)	1985-01-14	1986-09-12	Analogifremgangsmaate til fremstilling av terapeutisk aktive o-glykosidforbindelser.

Country Status (13)

Country	Link
US (1)	US4868289A (no)
EP (1)	EP0208749B1 (no)
JP (1)	JP2510176B2 (no)
CN (1)	CN1022687C (no)
AU (1)	AU588854B2 (no)
CA (1)	CA1316170C (no)
DE (1)	DE3663029D1 (no)
DK (1)	DK17685D0 (no)
FI (1)	FI83659C (no)
IE (1)	IE58778B1 (no)
IL (1)	IL77602A (no)
NO (1)	NO166865C (no)
WO (1)	WO1986004065A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5314642A (en) *	1984-11-27	1994-05-24	Igen, Inc.	Interaction system comprising a surfactant-stabilized aqueous phase containing an antibody fragment
DK17785D0 (da) *	1985-01-14	1985-01-14	Hans Goeran Magnusson	Propanolderivater
ZA872203B (en) *	1986-04-28	1988-02-24	New York Blood Center Inc	Complex immunogen containing synthetic peptides
WO1989008499A1 (fr) *	1988-03-17	1989-09-21	Nippon Fine Chemical Co., Ltd.	Liposome
DK455088D0 (da) *	1988-08-12	1988-08-12	Symbicom Ab	Syntetiske receptoranaloger
JP2694282B2 (ja) *	1988-09-02	1997-12-24	大塚製薬株式会社	グリコシル化法
US5141925A (en) *	1990-04-23	1992-08-25	Trustees Of Tufts College	Vivo methods for treating coccidiosis
US5241072A (en) *	1990-05-25	1993-08-31	Genzyne Corporation	Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof
US5846951A (en) *	1991-06-06	1998-12-08	The School Of Pharmacy, University Of London	Pharmaceutical compositions
GB9112212D0 (en) *	1991-06-06	1991-07-24	Gregoriadis Gregory	Pharmaceutical compositions
DE59208378D1 (de) *	1991-09-04	1997-05-28	Ciba Geigy Ag	Verfahren zur Herstellung von Glykosiden
US5409902A (en) *	1991-12-31	1995-04-25	Lever Brothers Company	Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
DE69316754T2 (de) *	1992-06-01	1998-07-16	Biomembrane Inst	Schrittweise entfernung von monosacchariden vom reduzierenden ende von oligosacchariden und verwendungen davon
EP0601417A3 (de) *	1992-12-11	1998-07-01	Hoechst Aktiengesellschaft	Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung
WO1994020116A1 (en) *	1993-03-10	1994-09-15	University Of Alabama Research Foundation	Artificial primers for glycogen synthesis
US5661130A (en) *	1993-06-24	1997-08-26	The Uab Research Foundation	Absorption enhancers for drug administration
DK76193D0 (da) *	1993-06-25	1993-06-25	Astra Ab	Kulhydratderivater
US5891862A (en)	1996-03-15	1999-04-06	Geltex Pharmaceuticals, Inc.	Polyvalent polymers for the treatment of rotavirus infection
US5700458A (en)	1996-09-20	1997-12-23	Geltex Pharmaceuticals Inc.	Acid-functionalized saccharides as polyvalent anti-infectives
US5973128A (en) *	1996-11-22	1999-10-26	The Hospital For Sick Children Research And Development Lp	Glycolipid mimics and methods of use thereof
DE19728900A1 (de) *	1997-07-07	1999-01-14	Henkel Kgaa	Hydrophile Glykoside
FI20010118A7 (fi) *	2001-01-19	2002-07-20	Carbion Oy	Uudet helicobacter pylori reseptorit ja niiden käyttö
US20050096446A1 (en) *	2003-10-29	2005-05-05	Council Of Scientific And Industrial	Tri-block copolymers and a process for the preparation of the same
US20140162965A1 (en)	2004-08-25	2014-06-12	Aegis Therapeutics, Inc.	Compositions for oral drug administration
US20090047347A1 (en) *	2005-07-29	2009-02-19	Aegis Therapeutics, Inc.	Compositions for Drug Administration
US20060046962A1 (en)	2004-08-25	2006-03-02	Aegis Therapeutics Llc	Absorption enhancers for drug administration
US9895444B2 (en)	2004-08-25	2018-02-20	Aegis Therapeutics, Llc	Compositions for drug administration
US8268791B2 (en) *	2004-08-25	2012-09-18	Aegis Therapeutics, Llc.	Alkylglycoside compositions for drug administration
MX2007010306A (es) *	2005-02-23	2007-09-26	Uab Research Foundation	Vacunacion mejorada con alquil-glicosido.
US8226949B2 (en)	2006-06-23	2012-07-24	Aegis Therapeutics Llc	Stabilizing alkylglycoside compositions and methods thereof
JP4636041B2 (ja)	2007-03-14	2011-02-23	日立工機株式会社	打込機
EP2271347B1 (en)	2008-03-28	2016-05-11	Hale Biopharma Ventures, Llc	Administration of benzodiazepine compositions
US8440631B2 (en) *	2008-12-22	2013-05-14	Aegis Therapeutics, Llc	Compositions for drug administration
CN103796656A (zh)	2011-06-14	2014-05-14	哈尔生物药投资有限责任公司	苯二氮卓的投与

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2252706A (en) *	1938-10-20	1941-08-19	Squibb & Sons Inc	Haloalkyl polyacyl glycosides
US3843626A (en) *	1968-12-31	1974-10-22	Smithkline Corp	Anti-inflammatory compositions containing acylated-b-d-glucopyranosides and methods of using them
US4016261A (en) *	1973-03-01	1977-04-05	Strategic Medical Research Corporation	Therapeutic composition and method of therapeutically treating warm blooded animals therewith
US3965262A (en) *	1973-03-01	1976-06-22	Strategic Medical Research Corporation	Method of enhancing learning and/or memory in warm blooded animals
US3939146A (en) *	1973-03-01	1976-02-17	Strategic Medical Research Corporation	Novel ethereal monosubstitutions of monosaccharide derivatives
US3939145A (en) *	1973-03-01	1976-02-17	Strategic Medical Research Corporation	Novel ethereally monosubstituted monosaccharides
US4017608A (en) *	1973-12-14	1977-04-12	Strategic Medical Research Corporation	Therapeutic composition and method of therapeutically treating warm blooded animals therewith
US4056322A (en) *	1973-12-14	1977-11-01	Strategic Medical Research Corporation	Preparation of ethers of monosaccharides
AU1227276A (en) *	1975-03-28	1977-09-29	Strategic Medical Res Corp	Ethers of monosaccarides
GB1544908A (en) *	1975-07-08	1979-04-25	Chembiomed Ltd	Artificial oligosaccharide antigenic determinants
FR2509313A1 (fr) *	1981-07-08	1983-01-14	Choay Sa	Derives de 3-fucosyl-n-acetyl lactosamine, leur preparation et leurs applications biologiques
AU561067B2 (en) *	1982-03-22	1987-04-30	Biocarb Ab	Anti-bacterial composition containing an oligosaccharide
SE8203925D0 (sv) *	1982-06-23	1982-06-23	Svenska Sockerfabriks Ab	New and novel glycosides, glycoconjugates and processes for their preparation
US4557931A (en) *	1982-12-02	1985-12-10	Regents Of The University Of California	Antigenic compositions and methods for using same
SE8301609D0 (sv) *	1983-03-23	1983-03-23	Svenska Sockerfabriks Ab	Forening och komposition for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutisk behandling

1985
- 1985-01-14 DK DK17685A patent/DK17685D0/da not_active Application Discontinuation
1986
- 1986-01-10 IE IE7786A patent/IE58778B1/en not_active IP Right Cessation
- 1986-01-13 AU AU53515/86A patent/AU588854B2/en not_active Ceased
- 1986-01-13 EP EP86900752A patent/EP0208749B1/en not_active Expired
- 1986-01-13 US US06/907,690 patent/US4868289A/en not_active Expired - Fee Related
- 1986-01-13 WO PCT/DK1986/000006 patent/WO1986004065A1/en not_active Ceased
- 1986-01-13 DE DE8686900752T patent/DE3663029D1/de not_active Expired
- 1986-01-13 JP JP61500822A patent/JP2510176B2/ja not_active Expired - Lifetime
- 1986-01-14 CA CA000499564A patent/CA1316170C/en not_active Expired - Fee Related
- 1986-01-14 CN CN86100178A patent/CN1022687C/zh not_active Expired - Fee Related
- 1986-01-14 IL IL77602A patent/IL77602A/xx not_active IP Right Cessation
- 1986-09-12 FI FI863703A patent/FI83659C/fi not_active IP Right Cessation
- 1986-09-12 NO NO863645A patent/NO166865C/no unknown

Also Published As

Publication number	Publication date
NO863645D0 (no)	1986-09-12
US4868289A (en)	1989-09-19
EP0208749A1 (en)	1987-01-21
JP2510176B2 (ja)	1996-06-26
EP0208749B1 (en)	1989-04-26
NO166865B (no)	1991-06-03
FI863703A0 (fi)	1986-09-12
IE860077L (en)	1986-07-14
JPS62502258A (ja)	1987-09-03
FI863703L (fi)	1986-09-12
IE58778B1 (en)	1993-11-17
DE3663029D1 (en)	1989-06-01
CN86100178A (zh)	1987-07-15
CA1316170C (en)	1993-04-13
NO863645L (no)	1986-11-13
CN1022687C (zh)	1993-11-10
WO1986004065A1 (en)	1986-07-17
IL77602A (en)	1993-05-13
AU5351586A (en)	1986-07-29
FI83659C (fi)	1991-08-12
DK17685D0 (da)	1985-01-14
AU588854B2 (en)	1989-09-28
FI83659B (fi)	1991-04-30

Publication	Publication Date	Title
NO166865C (no)	1991-09-11	Analogifremgangsmaate til fremstilling av terapeutisk aktive o-glykosidforbindelser.
NO163857C (no)	1990-08-01	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindionforbindelser.
NO872946D0 (no)	1987-07-15	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO162113C (no)	1989-11-08	Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminforbindelser.
NO164025C (no)	1990-08-22	Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO159016C (no)	1988-11-23	Analogifremgangsmaate for fremstilling av terapeutisk aktive fenetanolaminderivater.
NO162189C (no)	1989-11-29	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner.
NO165397C (no)	1991-02-06	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO166367C (no)	1991-07-10	Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
NO167200C (no)	1991-10-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive urinstoff-forbindelser.
NO161497C (no)	1989-08-23	Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO864110D0 (no)	1986-10-15	Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO163619C (no)	1990-06-27	Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro- 2-heterocykloalkylpyrido(4,3)indoler.
NO164295C (no)	1990-09-19	Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.
NO164541C (no)	1990-10-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO169963C (no)	1992-08-26	Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner
NO163775C (no)	1990-07-18	Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolinyl-alkyl-piperaziner.
NO165842C (no)	1991-04-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO164172C (no)	1990-09-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske tienokondenserte forbindelser.
NO861584L (no)	1986-10-24	Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO165916C (no)	1991-05-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive, ikke-aromatiske fluorallylamin mao-inhibitorer.
NO164899C (no)	1990-11-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO873680L (no)	1988-03-04	Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO163570C (no)	1990-06-20	Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO162188C (no)	1989-11-29	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.